0001209191-23-057548.txt : 20231205
0001209191-23-057548.hdr.sgml : 20231205
20231205185752
ACCESSION NUMBER: 0001209191-23-057548
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ansari Aseem Z.
CENTRAL INDEX KEY: 0001849177
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40288
FILM NUMBER: 231468060
MAIL ADDRESS:
STREET 1: C/O DESIGN THERAPEUTICS, INC.
STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Design Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823929248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
BUSINESS PHONE: 858-293-4900
MAIL ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-01
0
0001807120
Design Therapeutics, Inc.
DSGN
0001849177
Ansari Aseem Z.
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD
CA
92011
0
0
1
0
0
Stock Option (right to buy)
2.51
2023-12-01
4
A
0
100000
0.00
A
2033-11-30
Common Stock
100000
100000
D
The shares subject to the option will vest as follows: 25% of the shares will vest on October 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period.
/s/ Mustapha Parekh, Attorney-in-Fact
2023-12-05